171 related articles for article (PubMed ID: 16111394)
21. Short-term direct, and macrophage stimulated, bactericidal properties of antigen-activated lymph node cell culture fluids.
Parish WE; Wardle GR; Cowan SI
Scand J Respir Dis Suppl; 1974; 89():15-28. PubMed ID: 4137926
[No Abstract] [Full Text] [Related]
22. [Macrophage migration inhibition factor].
Medunitsyn NV
Usp Sovrem Biol; 1977; 84(2):248-56. PubMed ID: 341567
[No Abstract] [Full Text] [Related]
23. [The mechanism of the in vitro migration inhibition test (author's transl)].
Sabioncello A; Dekaris D
Lijec Vjesn; 1978 Sep; 100(9):535-42. PubMed ID: 368478
[No Abstract] [Full Text] [Related]
24. [Letter: Leukocyte migration test in the diagnosis of drug allergy. A useful test].
Pupil P; Moneret-Vautrin DA; Savinet H
Nouv Presse Med; 1974 Sep; 3(31):1956. PubMed ID: 4444939
[No Abstract] [Full Text] [Related]
25. [Basic and clinical significance of lymphokines with special reference to migration inhibitory factor].
Acki T; Niinaka T
Nihon Rinsho; 1972 Feb; 30(2):615-28. PubMed ID: 4552559
[No Abstract] [Full Text] [Related]
26. Cell migration inhibition: an appraisal.
Morley J
Acta Allergol; 1974 Jun; 29(3):185-208. PubMed ID: 4277394
[No Abstract] [Full Text] [Related]
27. [Clinical significance of the leukocyte migration inhibition test].
Aoki T
Nihon Rinsho; 1990 Feb; 48 Suppl():730-3. PubMed ID: 2355604
[No Abstract] [Full Text] [Related]
28. [Technical guidelines for the macrophage migration inhibition test].
Anders L; Rindfleisch B
Z Med Labortech; 1970; 11(6):313-7. PubMed ID: 5514085
[No Abstract] [Full Text] [Related]
29. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
Youngner JS; Salvin SB
J Immunol; 1973 Dec; 111(6):1914-22. PubMed ID: 4356326
[No Abstract] [Full Text] [Related]
30. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
31. Relation between delayed hypersensitivity and immunity in tuberculosis.
Youmans GP
Am Rev Respir Dis; 1975 Feb; 111(2):109-18. PubMed ID: 803355
[No Abstract] [Full Text] [Related]
32. Macrophage inhibitory factor (MIF): properties and role in delayed-type hypersensitivity.
Landolfo S
G Batteriol Virol Immunol; 1977; 70(7-12):137-43. PubMed ID: 355031
[No Abstract] [Full Text] [Related]
33. [Clinical significance of in-vitro methods for the demonstration of cellular immunity].
Malchow H; Sodomann CP
Internist (Berl); 1972 Feb; 13(2):66-8. PubMed ID: 4554752
[No Abstract] [Full Text] [Related]
34. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)].
Aoki T
Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741
[No Abstract] [Full Text] [Related]
35. [Allergy to sulfanilamides, demonstration using the macrophage migration inhibition test].
Rytter M; Barth J
Z Hautkr; 1974 Oct; 49(19):847-51. PubMed ID: 4464726
[No Abstract] [Full Text] [Related]
36. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
Matsui Y; Oshima S
Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
[No Abstract] [Full Text] [Related]
37. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
[TBL] [Abstract][Full Text] [Related]
38. Delayed hypersensitivity reactions in guinea-pigs using cotton pellets; demonstration of macrophage migration inhibition activity in the cell free exudate.
Yamamoto S; Ishikura A
J Pathol; 1979 Jan; 127(1):1-10. PubMed ID: 381610
[TBL] [Abstract][Full Text] [Related]
39. Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes.
Chess L; Rocklin RE; MacDermott RP; David JR; Schlossman SF
J Immunol; 1975 Jul; 115(1):315-7. PubMed ID: 50357
[No Abstract] [Full Text] [Related]
40. [Lymphocyte migration inhibition test in (MIT) in collagen diseases].
Del Rey Calero J; Calbo Torrecillas F
Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1367-82. PubMed ID: 5525223
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
